The trading price of Lipella Pharmaceuticals Inc (NASDAQ:LIPO) floating higher at last check on current market day and closing at $4.08, 33.77% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it has been fluctuating between $3.95 and $4.6799. In examining the 52-week price action we see that the stock hit a 52-week high of $12.00 and a 52-week low of $2.21. Over the past month, the stock has gained 40.69% in value.
Lipella Pharmaceuticals Inc, whose market valuation is $4.94 million at the time of this writing, is expected to release its quarterly earnings report in March. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest LIPO has a 25% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Buy.
A quick review shows that LIPO’s price is currently 37.11% off the SMA20 and 37.21% off the SMA50. The RSI metric on the 14-day chart is currently showing 61.03, and weekly volatility stands at 28.97%. When measured over the past 30 days, the indicator reaches 11.58%. Lipella Pharmaceuticals Inc (NASDAQ:LIPO)’s beta value is currently sitting at 0.21, while the Average True Range indicator is currently displaying 0.67. With analysts defining $2-$2 as the low and high price targets, we arrive at a consensus price target of $2 for the trailing 12-month period. The current price is about 50.98% off the estimated low and 50.98% off the forecast high, based on this estimate. Investors will be thrilled if LIPO’s share price rises to $2, which is the median consensus price. At that level, LIPO’s share price would be 50.98% above current price.
To see how Lipella Pharmaceuticals Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: LIPO stock’s performance was 33.77% at last check in today’s session, and -49.00% in the past year.
An evaluation of the daily trading volume of Lipella Pharmaceuticals Inc (NASDAQ:LIPO) indicates that the 3-month average is 1.57 million. However, this figure has increased over the past 10 days to an average of 8.99.
Currently, records show that 1.09 million of the company’s shares remain outstanding. The insiders hold 25.35% of outstanding shares, whereas institutions hold 5.87%. The stats also highlight that short interest as of 2024-10-31, stood at 2273.0 shares, resulting in a short ratio of 0.01 at that time. From this, we can conclude that short interest is 26.00 of the company’s total outstanding shares. It is noteworthy that short shares in October were down slightly from the previous month’s figure, which was 22482.0. However, since the stock’s price has seen 33.77% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
